IDT's library prep solutions join Illumina's extensive software ecosystem to enable streamlined analysis for IDT's FFPE and ...

Integrated DNA Technologies a annoncé une collaboration stratégique avec Illumina, Inc. afin de permettre le déploiement d'un pipeline d'analyse secondaire DRAGEN pour la préparation ...

At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the unique timsMRMS system, bringing the power of trapped ion mobility separation to ultra-high-resolution magnetic resonance mass ...

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for ...

The DEPArray™ Kits streamline and optimize the analysis of FFPE samples by providing DEPArray™ users a fast and easy workflow, for a precise genetic analysis on pure cancer and stromal cell ...

Saves labware, resources, and time Preserves frequently finite FFPE sample Increases the accuracy of tumor profiling by mitigating the bias caused by FFPE sample variability Compared to parallel or ...

PacBio a annoncé le début des expéditions mondiales de la chimie de séquençage SPRQ-Nx et des nouvelles cellules SMRT multi-usages destinées à sa plateforme de séquençage Revio HiFi.

Chicago precision‑medicine player Tempus has scored a fresh nod from the U.S. Food and Drug Administration, landing a tumor‑only indication for its xT CDx next‑generation sequencing platform. In ...

Repository containing all files related to the Giotto Suite manuscript - drieslab/Giotto_Suite_manuscript ...